In the same way that ChatGPT understands human language, a new AI model developed by Columbia computational biologists captures the language of cells to accurately predict their activities.
By generating movies of individual molecules performing actions that make our bodies tick, Columbia researchers have a deeper understanding of a process important in cancer and other diseases.
A new study shows that some of our cells favor genes of one parent or the other and can explain a longstanding mystery of why some people with disease-causing genes experience no symptoms.
Future treatments for hearing loss—including gene therapy—could come to rely on a tiny 3D-printed microneedle designed by a close-knit team of Columbia physicians and engineers.
A study revealing new structural details of an intracellular channel that controls muscle contraction may lead to new drugs for heart and muscle diseases.
A lightning-fast camera paired with an electron microscope has enabled Columbia scientists to capture images of one of the smallest proteins in our cells.
People with moderate or severe pain have a 41 percent higher risk of developing prescription opioid use disorders, researchers at Columbia University Medical Center have found.
Intranasal flu vaccines may provide long-lasting protection against pandemic flu strains, according to a study from immunologists at Columbia University Medical Center.
Columbia University has received a $58.4 million grant from the NIH's National Center for Advancing Translational Sciences to expand its work in translational research.